酵素结合免疫吸附检测法市场规模、份额、成长分析（按产品类型、应用、技术、最终用户和地区）- 2025 年至 2032 年产业预测

预计 2023 年全球酵素结合免疫吸附检测法市场价值将达到 24 亿美元，并从 2024 年的 25 亿美元成长到 2032 年的 35 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.1%。

由于慢性病和感染疾病的流行、检测技术的进步以及在药物研发和食品安全领域的广泛应用，全球酵素结合免疫吸附检测法(ELISA) 市场正在经历显着增长。 ELISA 能够准确定量抗原和抗体，这使得它在不断发展的以预防为主的医疗环境中能够及时诊断和介入。此外，它在疫苗研发和品管中的关键作用也使其在製药公司中的重要性日益凸显。此外，在人工智慧、机器学习和物联网 (IoT) 的整合推动下，市场也正在经历变革时期，这些技术提高了诊断的准确性和实验室的效率。这些技术确保 ELISA 在不断发展的诊断环境中始终是不可或缺的尖端工具，满足了人们对可靠结果日益增长的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 主要和次要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 使用案例

酵素结合免疫吸附检测法市场规模（依产品类型及复合年增长率） (2025-2032)

• 市场概览
• 套件
• 试剂
• 装置

酵素结合免疫吸附检测法市场规模：依应用及复合年增长率（2025-2032）

• 市场概览
• 临床诊断
• 研究
• 兽医
• 其他的

酵素结合免疫吸附检测法市场规模：依技术及复合年增长率（2025-2032）

• 市场概览
• 夹心 ELISA
• 间接酵素连结免疫吸附试验
• 竞争性 ELISA
• 直接 ELISA

酵素结合免疫吸附检测法市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 医院
• 诊断实验室
• 研究所
• 其他的

酵素结合免疫吸附检测法市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益同比对比（2022-2024 年）

    主要企业简介

    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Abcam plc
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • R&D Systems, Inc.
    • Enzo Life Sciences, Inc.
    • Ortho Clinical Diagnostics
    • BioLegend, Inc.
    • RayBIoTech, Inc.
    • QIAGEN NV
    • GenScript BIoTech Corporation

结论和建议

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.4 Billion in 2023 and is poised to grow from 2.5 USD Billion in 2024 to USD 3.5 Billion by 2032, growing at a CAGR of 5.1% in the forecast period (2025-2032).

The global enzyme-linked immunosorbent assay (ELISA) market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technologies, and a broader range of applications in drug discovery and food safety. ELISA's precision in quantifying antigens and antibodies enhances its appeal for timely diagnosis and intervention in an evolving healthcare landscape focusing on prevention. Furthermore, its vital role in vaccine development and quality control bolsters its relevance among pharmaceutical organizations. The market is also undergoing transformation through the integration of artificial intelligence, machine learning, and IoT, which improve diagnostic accuracy and laboratory efficiency. These technologies ensure ELISA remains an indispensable, cutting-edge tool in the evolving diagnostic landscape, catering to rising demand for reliable results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

A key market driver for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market is the increasing prevalence of chronic diseases and the rising demand for accurate diagnostic tools. As healthcare systems worldwide strive for improved disease management and early detection, ELISA techniques are gaining prominence due to their sensitivity, specificity, and versatility in detecting a range of biomarkers. This trend is further amplified by advancements in biotechnology and pharmaceuticals, which are driving research and development of novel assays. Additionally, the growing emphasis on personalized medicine and preventive healthcare is propelling the demand for ELISA tests in clinical and research settings.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

One of the key market restraints for the global enzyme-linked immunosorbent assay (ELISA) market is the high cost associated with advanced ELISA diagnostic kits and necessary laboratory equipment. These expenses can limit accessibility for smaller laboratories and healthcare facilities, especially in developing regions where budget constraints are more pronounced. Additionally, the complexity of ELISA procedures may require specialized training for personnel, further compounding costs and contributing to the potential inefficiencies in workflow. As a result, these financial and logistical challenges may hinder the widespread adoption of ELISA technologies, impacting market growth and innovation.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is witnessing a significant trend towards the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating advanced automated ELISA analyzers, which enhance efficiency by automating processes such as plate loading, reagent dispensing, and result reporting. This automation mitigates human error and accelerates turnaround times, making it particularly advantageous in high-demand contexts like pharmaceutical research and vaccine development, where processing large volumes of samples swiftly is essential. This shift towards automation is poised to transform ELISA applications, contributing to improved diagnostics and research outcomes across various sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Kits
• Reagents
• Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Research
• Veterinary
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sandwich ELISA
• Indirect ELISA
• Competitive ELISA
• Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations